$4.55
-0.01000-0.22%
In chiusura: -
$4.55
0.000.00%
After hour: Oct 3, 5:39 PM EDT
Acurx Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Acurx Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ACXP | Acurx Pharmaceuticals | -$3.40 | -$1.54 | — | — | $0.00 | — | — | — | 11/12/2025 | |
ACXP | Acurx Pharmaceuticals | -$5.21 | -$2.06 | -$1.89 | 8.25% | $0.00 | — | $0.00 | — | 08/12/2025 | |
ACXP | Acurx Pharmaceuticals | -$5.60 | -$5.80 | -$2.20 | 62.07% | $0.00 | — | $0.00 | — | 05/13/2025 | |
ACXP | Acurx Pharmaceuticals | -$7.70 | -$3.60 | -$3.40 | 5.56% | $0.00 | — | $0.00 | — | 03/18/2025 | |
ACXP | Acurx Pharmaceuticals | -$4.80 | -$4.00 | -$3.40 | 15.00% | $0.00 | — | $0.00 | — | 11/12/2024 | |
ACXP | Acurx Pharmaceuticals | -$5.60 | -$4.40 | -$5.20 | -18.18% | $0.00 | — | $0.00 | — | 08/09/2024 | |
ACXP | Acurx Pharmaceuticals | -$5.00 | -$4.80 | -$5.60 | -16.67% | $0.00 | — | $0.00 | — | 05/14/2024 | |
ACXP | Acurx Pharmaceuticals | -$5.60 | -$5.20 | -$7.40 | -42.31% | $0.00 | — | $0.00 | — | 03/18/2024 | |
ACXP | Acurx Pharmaceuticals | -$6.40 | -$5.40 | -$4.80 | 11.11% | $0.00 | — | $0.00 | — | 11/14/2023 | |
ACXP | Acurx Pharmaceuticals | -$5.20 | -$5.80 | -$5.60 | 3.45% | $0.00 | — | $0.00 | — | 08/11/2023 | |
ACXP | Acurx Pharmaceuticals | -$5.20 | -$5.80 | -$5.00 | 13.79% | $0.00 | — | $0.00 | — | 05/12/2023 | |
ACXP | Acurx Pharmaceuticals | -$4.40 | -$7.00 | -$5.60 | 20.00% | $0.00 | — | $0.00 | — | 03/16/2023 | |
ACXP | Acurx Pharmaceuticals | -$9.20 | -$7.00 | -$6.40 | 8.57% | $0.00 | — | $0.00 | — | 11/14/2022 | |
ACXP | Acurx Pharmaceuticals | -$11.40 | -$7.00 | -$5.20 | 25.71% | $0.00 | — | $0.00 | — | 08/15/2022 | |
ACXP | Acurx Pharmaceuticals | -$4.20 | -$6.60 | -$5.20 | 21.21% | $0.00 | — | $0.00 | — | 05/11/2022 | |
ACXP | Acurx Pharmaceuticals | — | -$8.00 | -$4.40 | 45.00% | $0.00 | — | $0.00 | — | 03/17/2022 | |
ACXP | Acurx Pharmaceuticals | -$4.20 | — | -$9.20 | — | $0.00 | — | $0.00 | — | 11/15/2021 | |
ACXP | Acurx Pharmaceuticals | -$3.00 | — | -$11.60 | — | $0.00 | — | $0.00 | — | 08/16/2021 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-12 | $-1.89 | $-2.06 | 8.25 % |
Q1 | 2025-05-13 | $-2.20 | $-5.80 | 62.1 % |
Q4 | 2025-03-18 | $-3.40 | $-3.60 | 5.56 % |
Q3 | 2024-11-12 | $-3.40 | $-4.00 | 15.0 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Si prevede che Acurx Pharmaceuticals (ACXP) fornisca risultati il novembre 12, 2025. Gli ultimi risultati sono stati pubblicati il agosto 12, 2025 per il Q2.
L'EPS effettivo era $-1.89, che superato la stima di $-2.06.
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.